VIP and rheumatoid arthritis: In this regard, the landscape can be even more complex, since we have recently described that genetic variants in the region encoding for vasoactive intestinal peptide (VIP), which have not been associated with the risk of developing RA, contribute to the heterogeneity of disease severity8.